---
title: "bioMérieux Receives US FDA Clearance for Updated Gastroenteritis Test"
date: "2025-02-11 17:51:47"
summary: "bioMérieux  received US clearance for the new version of its molecular test for the causes of gastroenteritis. The Biofire Filmarray Gastrointestinal Panel Mid test can detect 11 common pathogens through a single sample, the biotechnology company said Tuesday. It received approval from the US Food and Drug Administration."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

bioMérieux received US clearance for the new version of its molecular test for the causes of gastroenteritis.

The Biofire Filmarray Gastrointestinal Panel Mid test can detect 11 common pathogens through a single sample, the biotechnology company said Tuesday.

It received approval from the US Food and Drug Administration.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250211:G2466264:0/)
